Skip to content

4Accepted Jul 1, 2:16 PM ET

Select Medical (SEM) EVP Martin Jackson Sells 1.39M Shares

SEMSELECT MEDICAL HOLDINGS CORP

Accepted (ET)

2:16 PM

Jul 1, 2026

Filed

Jul 1, 2026

Documents

2

Size

20.2 KB

Summary

Select Medical (SEM) EVP Martin Jackson Sells 1.39M Shares

Updated

What Happened
Martin F. Jackson, Executive Vice President of Select Medical Holdings Corp (SEM), reported disposal of a total of 1,393,957 SEM shares on 2026-06-30. The reported disposals consist of 1,383,421 shares (comprised of 1,138,754 common and 244,667 restricted shares per footnote) plus four smaller entries of 2,634 shares each. All transactions show $0.00 per share (total proceeds $0) because the shares were transferred under a merger agreement and converted into interests of the acquiring parent company rather than sold for cash.

Key Details

  • Transaction date: 2026-06-30; Form 4 filed: 2026-07-01 (timely).
  • Shares disposed: 1,393,957 total (1,383,421 + 4×2,634). Price: $0.00; reported cash proceeds: $0.
  • Reason: Dispositions were made pursuant to the Agreement and Plan of Merger (see footnote F1). Per footnotes, shares were contributed to Stallion Intermediate Corporation/Parent, exchanged for Parent common shares, then converted into interests in Stallion Group Parent, LP (F2, F3).
  • Ownership after transaction: the reporting person’s SEM shares were converted into parent interests; the Form notes the reporting person beneficially owns the reported securities indirectly and disclaims beneficial ownership except for any pecuniary interest (F4).
  • Filing timeliness: filed promptly (no late filing indicated).

Context
This was a merger-related, non-cash transfer (conversion into parent company interests), not an open-market sale, so there were no cash proceeds and it should not be read as routine insider selling for liquidity. The filing documents a structural corporate transaction rather than an executive decision to sell shares on the market.

AI-written summary · check the filing